SLC39A7 and breast cancer: Studies have highlighted the role of zinc in the etiology of breast cancer where high expression of zinc transporter proteins such as ZIP7 and ZIP10, in breast cancer cell models increases intracellular zinc levels and is associated with endocrine therapy resistance and increased invasiveness [10], [11].